Dapsone

Quick links to important sections

Dapsone

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dapsone

Property Description
Active Ingredient Dapsone (4,4′-diaminodiphenylsulfone)
Form Oral tablets, Topical gel
Pharmacological Class Sulfone, Anti-infective, Antibacterial
Common Use Combating specific infections and inflammatory conditions
Origin Synthetic substance (Aniline derivative)

What Type of Medicine is Dapsone?

Dapsone, chemically identified as 4,4′-diaminodiphenylsulfone (DDS), is a potent, synthetic organic compound that defines the sulfone class of medicines. It is primarily categorized as an anti-infective and antibacterial agent. This unique classification sets it apart from other antibiotics, and Dapsone is utilized as a single active ingredient in its medicinal preparations. Dapsone is effective in treating certain specific conditions due to its anti-infective properties. This means the drug works by combating the specific microorganisms that cause certain diseases.


What are the Available Forms of Dapsone?

Dapsone is formulated from a crystalline powder into two main pharmaceutical preparations to allow for different methods of administration: oral tablets and a topical gel. The oral tablets are designed for systemic absorption, allowing the medicine to work internally throughout the body. Conversely, the topical gel is engineered for localized delivery directly to the skin. Dapsone is used in treating dermatological inflammatory conditions, providing utility in a topical preparation. The development of the topical formulation marked an advance, offering a way to target specific skin inflammation with less potential for systemic impact compared to the oral form.


What is the General Purpose of Dapsone?

The therapeutic general purpose of Dapsone is rooted in its dual function: it acts as both an antibacterial agent and possesses distinct anti-inflammatory properties. Its mechanism involves interfering with the synthesis of essential materials required by certain bacteria, thereby inhibiting their growth. Concurrently, Dapsone helps to calm excessive inflammation by modulating the activity of specific immune cells, such as neutrophils. This dual activity allows the medicine to be used not only for combating specific infections but also for alleviating symptoms associated with chronic inflammatory conditions.

Regulatory References

  1. MedlinePlus Drug Information - Dapsone

What side effects are possible with Dapsone?

Dapsone use is associated with a specific and significant safety profile, dominated by hematologic risks, hypersensitivity reactions, and the potential for peripheral nervous system and hepatic toxicity.

Adverse Reactions and Safety Considerations

Hematologic Effects

The most common adverse effects are dose-related hemolysis (breakdown of red blood cells) and methemoglobinemia (a blood disorder where oxygen delivery is impaired), which occur in nearly all patients. Anemia is common and usually mild. Rare but potentially fatal blood dyscrasias include agranulocytosis (a severe reduction in white blood cells) and aplastic anemia (failure of bone marrow to produce blood cells).

Serious and Clinically Significant Reactions

  • Dapsone Hypersensitivity Syndrome (DHS): A rare, potentially fatal systemic reaction (part of Drug Reaction with Eosinophilia and Systemic Symptoms - DRESS) typically occurring within the first six weeks of therapy. Symptoms include fever, rash, lymphadenopathy, and internal organ involvement, most commonly toxic hepatitis and cholestatic jaundice.
  • Peripheral Neuropathy: Predominantly motor weakness, associated mainly with high doses or long-term therapy.
  • Severe Skin Reactions: Including toxic epidermal necrolysis (TEN) and erythema multiforme.

Population-Specific Safety

Individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency are at significantly exaggerated risk for severe hemolytic anemia, necessitating screening before starting therapy. Dapsone should be used with caution, if at all, in these individuals. Use in pregnancy and lactation may carry a risk of neonatal hemolysis and cyanosis.

Safety Monitoring Notes

Regular monitoring of full blood counts (including differential white cell count) and liver function tests is critical due to the risk of serious blood disorders and hepatic injury. Patients must be advised to immediately report signs such as fever, sore throat, or jaundice.

Overdose and Emergency Response

The regulatory documentation defines Dapsone overdosage primarily by the onset of Hematologic Toxicity, specifically methemoglobinemia and resulting hypoxia. Clinical manifestations documented in official labeling include cyanosis (often described as slate grey), haemolytic anaemia, vomiting, tachycardia, and neurological signs like seizures or altered mental status. These symptoms are recognized as markers of a potentially severe overdosage.

Property Official Regulatory Statement
Emergency Action Seek immediate medical attention upon observing cyanosis or symptoms of severe toxicity.
Antidote Methylene blue (specific treatment for methemoglobinemia).
Supportive Measures Gastric lavage, oral activated charcoal, and symptomatic and supportive treatment.

Overdosage is classified as a severe event capable of causing life-threatening methemoglobinemia. Management requires close clinical and laboratory monitoring due to the risk of rebound methemoglobinemia stemming from the drug's prolonged half-life. Population-specific considerations are noted for patients with G6PD deficiency, who face increased risk for exaggerated hemolytic complications and for whom Methylene blue may be contraindicated in the official protocols. The official statements establish clear triggers that necessitate immediate medical help and outline the specific procedures and monitoring requirements exactly as described by regulatory authorities.

Therapeutic Uses of Dapsone

The primary therapeutic value of Dapsone generally supports both an anti-infective and an anti-inflammatory role, applicable across distinct symptomatic domains. The medication is used to address chronic infections and certain conditions that present with systemic or localized discomfort.


Key Therapeutic Domains

Dapsone is used to manage two primary categories of conditions: specific slow-progressing bacterial diseases, such as leprosy (Hansen's disease), and chronic, intensely symptomatic inflammatory skin disorders, like Dermatitis Herpetiformis (DH) and moderate inflammatory acne vulgaris.

In scenarios involving chronic infection, Dapsone is used to manage the infection itself, which may assist in managing the progression of the condition and contributes to easing the overall symptom load that may affect physical function. For inflammatory conditions, the focus is on providing supportive relief that helps ease the severe, disruptive itching and burning sensation that accompanies the characteristic skin lesions. This action assists with maintaining functional stability and contributing to improved comfort during symptomatic periods. For localized use, the medication is used for easing the swelling and redness in inflammatory acne lesions.


Quick Fact

Quick Fact: Relief for Intense Itching and Systemic Bacterial Load

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

The eligibility profile for Dapsone is strictly defined by regulatory documentation, establishing which populations are permitted to use the medicine and who is formally excluded.

Contraindications and Restrictions

Absolute Contraindications: Use is prohibited for individuals with a known hypersensitivity to Dapsone, other sulfonamides, or any of the product’s components. The topical gel is explicitly contraindicated in those with congenital or idiopathic methemoglobinemia. Additionally, patients with severe anemia must have the condition treated before Dapsone therapy can be initiated.

Conditional Use: Caution is advised for patients with underlying Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency or Methemoglobin Reductase Deficiency due to the higher risk of severe hematologic effects. Caution is also required for patients with existing hepatic or renal impairment.

Age and Reproductive Status

Age-Related Eligibility: The topical gel is approved for use in individuals 9 years of age and older. For the oral form, safety and efficacy have not been established in children under six years. No specific comparative data is available for use in older adults.

Pregnancy and Lactation: Dapsone is generally classified as FDA Pregnancy Category C and should only be used when the potential benefit outweighs the risk. During lactation, a regulatory decision must be made to discontinue nursing or discontinue the drug, as Dapsone is known to be excreted in human milk.

What should I know about interactions with other medicines?

Dapsone Interactions with Other Medicines and Products

Official regulatory information documents interactions between Dapsone and other substances based on their effects on drug exposure and additive pharmacodynamic risks.


Key Interaction Profiles

Interaction Type Interacting Substances (Official Documentation) Practical Regulatory Note
Increased Dapsone Exposure Trimethoprim, Cimetidine, Probenecid These combinations may increase Dapsone levels and require careful attention due to reduced clearance.
Decreased Dapsone Exposure Rifampin, St. John’s Wort, Anticonvulsants These substances, acting as enzyme inducers, can increase Dapsone's metabolic rate and clearance.
Additive Blood Risk Sulfonamides, Nitrates, Pyrimethamine Increases the risk of hematologic reactions, specifically methemoglobinemia and hemolytic effects.

Restrictions and Specific Cautions

Co-administration of the topical Dapsone gel is advised to be avoided with oral Dapsone or antimalarial medicines due to the heightened risk of hemolytic events. Furthermore, patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency are noted to be at a greater susceptibility for these blood-related interaction risks. A topical restriction exists: co-application of Dapsone gel immediately followed by Benzoyl Peroxide may cause temporary local discoloration of the skin and hair.

Mechanism of Action

How Dapsone Works: Mechanism of Action

Dapsone exerts its physiological effect through two primary and distinct mechanistic domains: anti-inflammatory action on host immune cells and antimicrobial action on pathogen metabolism.

Inhibition of Key Inflammatory Enzymes and Cells

This mechanism focuses on modulating the host's innate immune response by targeting the enzyme Myeloperoxidase (MPO), which is housed within white blood cells, specifically neutrophils. Dapsone restricts MPO's activity, limiting its ability to generate highly reactive oxygen species (ROS) and toxic oxidants. Furthermore, the drug suppresses neutrophil chemotaxis (migration). This mechanistic cascade attenuates the inflammatory response and decreases the concentration of cytotoxic mediators at sites of immune activity.

Antagonism of Bacterial Folic Acid Synthesis

This domain involves an antimicrobial mechanism where the drug acts as a competitive antagonist of the bacterial enzyme Dihydropteroate Synthase (DHPS). By structurally mimicking para-aminobenzoic acid (PABA), Dapsone blocks an initial step in the microbial synthesis of folic acid, a precursor essential for DNA and RNA production. The resulting physiological effect is the inhibition of growth and replication of susceptible microorganisms, establishing a bacteriostatic effect on the system.

Dosage and Administration Information

Dapsone is administered either as an oral tablet or a topical gel, and the usage instructions depend strictly on the formulation prescribed.

Oral Tablet Administration

For the oral tablet, which is typically used for conditions like leprosy or dermatitis herpetiformis, the prescribed dose is usually taken once a day. The specific starting dose, such as 50 mg daily for dermatitis herpetiformis, is subject to adjustment by the prescriber. The tablet may be taken with or without food. If a dose is missed, it is taken as soon as it is remembered; however, if it is almost time for the next scheduled dose, the missed dose is typically skipped to maintain the regularity of the schedule, and double doses are not taken.

Topical Gel Administration

The topical dapsone gel, indicated for acne treatment, is for external use only and is not used orally, or in the eyes, mouth, or vagina. The gel is applied to the affected area, usually once or twice daily. The application process involves first washing and gently drying the skin. Then, an approximate pea-sized amount of the gel is applied in a thin layer and rubbed in gently and completely. Hand washing is recommended immediately after applying the gel. If there is no improvement after 12 weeks, treatment continuation is reassessed by a healthcare provider. If a topical dose is missed, it is applied as soon as it is remembered, but skipped if the next application time is almost due.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Dapsone

Evidence for Use in Leprosy (Hansen's Disease) Multi-Drug Regimens

Dapsone has been studied extensively for its role in the multi-drug regimens (MDR) used for the long-term management of leprosy. Research in this area is largely based on decades of long-term observational cohort studies and clinical trials which examine how the multi-drug combination is used in the context of the disease. These studies focus on outcomes related to systemic or functional imbalance, such as tracking the microbiological state and assessing the rate of disease return, or relapse, after the treatment course is finished.

The research describes consistent patterns observed in the studies regarding the measurement of bacterial clearance following administration of the multi-drug regimen. However, because Dapsone is a standard component of the treatment protocols studied, there are few modern, large-scale placebo-controlled trials specifically studying Dapsone alone. Therefore, the evidence primarily describes Dapsone's role as a component of the overall multi-drug regimen, and its independent long-term effects, separate from the combination, are not fully established in the research.

Evidence for Use in Dermatitis Herpetiformis

Research exploring the use of Dapsone for Dermatitis Herpetiformis (DH), a condition characterized by periods of heightened symptoms, relies heavily on older clinical trials, case series, and retrospective studies. The research examined outcomes related to physical discomfort, focusing on the degree of intense itching and burning sensation that accompanies the skin lesions. Studies conducted during periods of increased symptom activity have described patterns where people reported changes in the severity of itching following the start of therapy.

The evidence quality varies across studies, and the research base includes a notable proportion of older, non-controlled study designs. This means that although short-term symptom patterns were observed, the follow-up durations were limited in many studies. Consequently, there is limited information for long-term outcomes regarding the durability of symptom control or Dapsone’s role in tracking or managing the underlying chronic disease process.

Evidence for Use in Moderate Inflammatory Acne Vulgaris (Topical Gel)

The topical gel formulation of Dapsone has been evaluated in multiple Randomized, Double-Blind, Placebo-Controlled Trials (RCTs), which are central to the regulatory research record. The research describes that the topical gel was evaluated by measuring the difference in inflammatory lesion counts when compared against the placebo gel. The Global Assessment scores documented patterns of change over the 12-week study period for the majority of the treated population.

While the evidence base for the short-term use of the topical gel includes multiple RCTs, comparative evidence is lacking from trials that directly test the topical gel against all other available acne treatments in the same study design.

Frequently Asked Questions (FAQ)

Common questions about Dapsone (FAQ)

Q: How quickly should I expect to see an effect from taking Dapsone?

A: The time to see an effect depends on the formulation and condition being addressed. For the topical gel used for acne, studies describe that reduction in inflammatory lesion counts can begin within about one month. Official regulatory documents indicate that the required time frame for dose adjustment for the oral tablet used for dermatitis herpetiformis may be extended, ranging from 8 months to over 2 years for some patients.

Q: What is the typical time frame before Dapsone reaches its full effect?

A: Studies on the topical gel for acne measured significant reduction in total lesions in controlled trials over a 12-week period, with long-term studies showing continued improvement for up to one year. Official regulatory descriptions for the oral tablet used in chronic conditions indicate that a stable, maximal effect can take a gradual and extended period of time.

Q: Is Dapsone a long-term treatment or is it usually taken only for a short period?

A: Dapsone is officially described as a drug used in long-term management for certain conditions. For instance, it is a standard component of multi-drug regimens used for leprosy. The topical gel formulation has also been evaluated in long-term safety studies lasting up to 12 months.

Q: Are the side effects of Dapsone permanent or do they usually go away?

A: According to official product information, most adverse reactions are described as having regressed off drug after discontinuation. Peripheral neuropathy, a serious reaction, is described in official documentation as having regressed off drug upon withdrawal. There are exceptions, such as complications resulting from severe overdosage.

Q: What should I do if I notice a rash while taking Dapsone?

A: Official warnings state that a rash can be a symptom of a severe systemic reaction, such as Dapsone Hypersensitivity Syndrome (DHS). Official guidance indicates that if new or toxic dermatologic reactions occur, prompt discontinuation of sulfone therapy is required.

Q: What percentage of patients report common side effects with Dapsone?

A: Dose-related hemolysis (red blood cell breakdown) and methemoglobinemia (impaired oxygen delivery) are noted to occur in nearly all patients taking the oral tablet. For the topical gel, application site issues like oiliness, peeling, and redness (erythema) are the most common localized adverse events, reported in up to 18% of subjects in clinical trials.

Q: What is the main difference between Dapsone and other antibiotics often used for skin conditions?

A: Dapsone is officially classified as a sulfone antibiotic that also acts as an anti-inflammatory agent. A key difference is Dapsone's dual mechanism: it slows microbial growth and modulates the host's innate immune response to decrease inflammation.

Q: How does the topical version of Dapsone differ from the oral version?

A: The two formulations differ significantly in their intended use and systemic exposure. The topical gel is for local treatment of acne and achieves minimal systemic absorption. The oral tablet is used for systemic conditions like leprosy and dermatitis herpetiformis and results in significant drug levels throughout the body.

Q: Is Dapsone appropriate for use in children?

A: The topical dapsone gel formulation is indicated for the treatment of acne in a broad population, including children, teenagers, and adults. The official documents describe dose adjustment for the oral tablet is typically determined by the prescriber.

Q: Why is Dapsone sometimes used for skin disorders that are not infections?

A: In addition to its bacteriostatic effects, the drug is recognized in regulatory-cited research for its anti-inflammatory properties. This is attributed to the drug’s anti-inflammatory properties, which is why it is used for inflammatory skin diseases like dermatitis herpetiformis.

Q: Is Dapsone considered a type of sulfa drug?

A: Dapsone is classified as a sulfone antibiotic. While chemically distinct from sulfonamide antibiotics, the official patient information advises individuals to state if they have an allergy to sulfonamide-derived medications (commonly known as 'sulfa drugs').

Q: Are there any vitamins or supplements that are known to interact with Dapsone?

A: Official drug interaction information notes that the herbal supplement St. John's Wort can decrease Dapsone's exposure. Other supplements, such as biotin, have been noted to have minor, potentially unknown significance interactions.

Q: Does Dapsone have known interactions with common herbal remedies?

A: Official documentation identifies the herbal product St. John’s Wort as a substance that may decrease Dapsone's exposure by increasing the rate at which the body metabolizes (breaks down) the drug.

Q: Can Dapsone be used by people who have diabetes?

A: Official warnings advise caution when Dapsone is used in patients exposed to conditions capable of producing hemolysis (red blood cell breakdown), such as diabetic ketosis. Official labeling states that Dapsone use has been associated with falsely reduced HbA1c measurements, which are commonly used to monitor blood sugar control.

Q: Does Dapsone have any impact on mental health or mood?

A: Official labeling lists several adverse reactions that may affect the central nervous system. Reported adverse reactions include psychosis, nervousness, and mood or other mental changes.

Q: What should I do if I feel dizzy after taking Dapsone?

A: Official labeling includes dizziness and vertigo among the reported adverse reactions. The patient counseling information describes seeking medical attention for more serious signs and symptoms.

Q: What class of drug does Dapsone belong to?

A: Dapsone is formally classified as a sulfone antibiotic and is described as a drug with anti-inflammatory properties. These classifications help to define the drug’s primary structural features and its main therapeutic actions.

Q: Does Dapsone affect fertility?

A: Official non-clinical toxicology studies for the topical dapsone gel do not document any specific findings regarding impairment of fertility.

Q: Is it possible to become resistant to Dapsone over time?

A: Regulatory-cited research notes that Dapsone resistance is a known factor, particularly in cases of relapse or when the drug was previously used as monotherapy (alone). The documented risk of Dapsone resistance is why the drug is generally used as part of multi-drug regimens for certain conditions.

Q: Why is Dapsone sometimes used in combination with other medications?

A: In conditions like leprosy, Dapsone is used in multi-drug regimens to prevent the development of drug resistance and to enhance overall treatment effectiveness. Resistance is strongly associated with using Dapsone by itself.

Q: Can Dapsone change the color of my skin or eyes?

A: Yes, changes in color have been reported as part of the known safety profile. Adverse reactions listed in official patient information include yellow eyes or skin (which may signal jaundice), and blue discoloration of lips and fingertips (cyanosis), which is related to a blood disorder known as methemoglobinemia.

Q: Does Dapsone need to be taken at a specific time of day?

A: The official instructions for the oral tablet state that it is typically taken once a day, and there is no specific time of day, such as morning or night, mandated in the instructions.

Q: Is it normal to have mild stomach upset when starting this medicine?

A: Yes, official labeling for the oral tablet lists mild nausea, vomiting, and abdominal pains as reported gastrointestinal side effects.

Q: Can Dapsone affect sleep patterns?

A: Official labeling for the oral tablet includes effects on sleep among the reported adverse reactions. Both insomnia (difficulty falling or staying asleep) and trouble in sleeping are listed.

Q: Is there a generic version of Dapsone available?

A: Yes, the FDA has approved generic versions of the topical dapsone gel (Aczone brand name) at both the 5% and 7.5% strengths. Multiple manufacturers currently hold approvals for these generic formulations.

Q: What does it mean that Dapsone is bacteriostatic?

A: This term describes the drug's antimicrobial effect. A bacteriostatic action means the drug works by slowing or stopping the growth and replication of susceptible microorganisms, rather than killing them outright.

Q: Is there evidence that Dapsone is effective for conditions beyond its main approved uses?

A: Regulatory-cited research notes that Dapsone is also prescribed for a wide range of skin diseases beyond its main approved uses, including conditions like neutrophilic dermatoses and vasculitis, due to its anti-inflammatory properties.

Q: Have there been any major recent studies about Dapsone's long-term safety?

A: Yes, the topical dapsone gel formulation has been evaluated in a 12-month, open-label, long-term safety study. This type of research assesses the drug's safety profile during extended use in patients with acne.

How should Dapsone be stored and disposed of?

The storage and disposal of Dapsone must adhere strictly to official regulatory guidelines to maintain product stability and safety.

Official Storage Requirements

Storage Factor Requirement
Temperature Store at Controlled Room Temperature (20 C to 25 C), with short excursions permitted to 30 C.
Protection Protect from light and store in a dry place. The topical gel formulation must be protected from freezing.
Container Keep the medication in the container it came in, and keep the container tightly closed.

Child Safety and Disposal

All Dapsone formulations must be kept out of the reach of children.

Unused or expired Dapsone must be disposed of properly according to official guidelines, such as those provided by the FDA or local regulatory requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dapsone found in:

A-Z Index: